Actively Recruiting
Time to Clearance of Chlamydia Trachomatis and Neisseria Gonorrhoeae RNA After Treatment: a Prospective Cohort Study
Led by University Hospital, Strasbourg, France · Updated on 2025-08-03
140
Participants Needed
1
Research Sites
186 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to evaluate the negativation time of chlamydial and gonococcal PCRs after treatment for urogenital, oropharyngeal and anal infections.
CONDITIONS
Official Title
Time to Clearance of Chlamydia Trachomatis and Neisseria Gonorrhoeae RNA After Treatment: a Prospective Cohort Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients attending the Trait d'Union department at the Nouvel H�f4pital Civil for PrEP consultations, AES or HIV infection
- Over 18 years of age
- Male or female
- Have had an uncomplicated CT and/or NG infection treated with currently recommended therapies (Ceftriaxone 500mg DU for NG infections, Doxycycline 200mg per day for 1 week for rectal CT infections and Azithromycin 1g DU or Doxycycline 7 days for other CT infections)
- Subject affiliated to a social health insurance scheme
- Subject able to understand the aims and risks of the research and to give dated and signed informed consent
You will not qualify if you...
- Complicated CT and/or NG infections such as epididymitis, prostatitis, upper genital infection, or extra-genital involvement (keratoconjunctivitis, arthritis, skin involvement, Fiessinger-Leroy-Reiter syndrome, Fitz-Hugh-Curtis syndrome)
- Severe immunosuppression including HIV with CD4 less than 200/mm3, chemotherapy in the last 6 months, active haemopathy, congenital immune deficiency, or immunosuppressive treatment including corticosteroid therapy for more than 4 weeks or organ transplant
- Inability to provide informed consent due to emergency situations or difficulties understanding
- Subject under court protection
- Subject under guardianship or curatorship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Service du Trait d'Union
Strasbourg, France, 67000
Actively Recruiting
Research Team
A
Axel Ursenbach, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here